Search
Showing results for "1"
We study the tidal interaction of galaxies in the Eridanus supergroup, using H i data from the pre-pilot survey of the Widefield ASKAP L-band Legacy All-sky Blind surveY.
Hemiplegic cerebral palsy (hCP) typically impacts sensorimotor control of the hand, but comprehensive assessments of the hands of children with hCP are relatively rare. This scoping review summarizes the development of hand function for children with hCP.
Antibodies that target immune checkpoints such as cytotoxic T lymphocyte antigen 4 (CTLA‐4) and the programmed cell death protein 1/ligand 1 (PD-1/PD-L1) are now a treatment option for multiple cancer types. However, as a monotherapy, objective responses only occur in a minority of patients. Chemotherapy is widely used in combination with immune checkpoint blockade (ICB). Although a variety of isolated immunostimulatory effects have been reported for several classes of chemotherapeutics, it is unclear which chemotherapeutics provide the most benefit when combined with ICB.
Asthma remission has emerged as a potential therapeutic goal. However, definitions of remission have primarily focused on adult populations, with limited consensus on how remission should be defined in children.
The WAACHS regional profiles look at all four volumes of results across the ATSIC regions of Western Australia.
A diabetes community session with a focus on healthy children.
We spoke to Oscar and asked him to share his story about the challenges he faces when trying to support his brother, joining the Centre as a student and what T1D research means to him, his brother and his family.
Diabetes Research Western Australia (DRWA) are inviting children aged 6-16 living with type 1 and type 2 diabetes to join West Coast Eagles forward Jamie Cripps for a fun-filled footy clinic.
The new automated insulin delivery system by MyLife Diabetes Care is now available on android devices from October 24, 2022.
Perth researchers have been awarded new West Australian funding to launch a pilot study into the use of oral insulin in type 1 diabetes – a medication intervention that could be a game-changer for those with the chronic condition.